Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target

Joon Won Yoon1, Richard Gilbertson, Stephen Iannaccone

  • 1Developmental Biology Program, Children's Memorial Research Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Insights

Sonic hedgehog pathway activation in medulloblastoma involves GLI1 target genes. Researchers identified specific GLI1-regulated genes contributing to tumor development and survival, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Medulloblastoma, a pediatric brain tumor, can exhibit constitutive activation of the Sonic hedgehog (SHH) signaling pathway.
  • GLI1 is a key transcription factor downstream of the SHH pathway, driving tumor growth.

Purpose of the Study:

  • To identify GLI1-target genes specifically involved in medulloblastoma.
  • To understand the molecular mechanisms by which GLI1 contributes to medulloblastoma tumorigenesis.

Main Methods:

  • Comparative gene expression profiling of GLI1-transformed RK3E cells and medulloblastoma samples.
  • Identification and validation of GLI1 binding sites in regulatory regions.
  • Analysis of gene expression changes and pathway involvement.

Main Results:

  • Identified 25 GLI1 target genes commonly altered in medulloblastomas.
  • Confirmed GLI1 binding and transcriptional regulation of specific target genes, including repression of Krox-20.
  • Observed upregulation of CXCR4, suggesting reinitiation of developmental programs.
  • Identified potential GLI1 targets converging on pathways regulating cell proliferation, survival, and genomic stability (p53, SGK1, MGMT, NTRK2).
  • Found a p53 mutation in GLI1-transformed cells, indicating a role in dysregulated cell survival.

Conclusions:

  • GLI1 directly regulates a specific set of genes in medulloblastoma.
  • Reactivation of developmental pathways and alterations in cell survival mechanisms contribute to medulloblastoma.
  • These findings provide insights into SHH-driven medulloblastoma pathogenesis and potential therapeutic strategies.